Tonix Pharma (TNXP) Tops Q2 EPS by 27c

Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($2.44), $0.27 better than the analyst estimate of ($2.71). Revenue for the quarter came in at $13.54 million versus the consensus estimate of $6.96 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• UBS Starts Internet Initiative Japan Inc (3774:JP) (IIJIY) at Neutral
• JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight